Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $79.93M.
ENTERPRISE VALUE (EV)
$79.93M
Milestone Pharmaceuticals Inc.
Market Cap
$95.14M
Enterprise Value (EV)
$79.93M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Milestone Pharmaceuticals Inc. (MIST) | $95.14M | $79.93M |
| Park Dental Partners, Inc. Common Stock (PARK)vs › | $93.96M | N/A |
| Korro Bio, Inc. (KRRO)vs › | $97.14M | $114.45M |
| PolyPid Ltd. (PYPD)vs › | $97.90M | $92.91M |
| Conexeu Sciences Inc. (CNXU)vs › | $97.94M | N/A |
| OnKure Therapeutics, Inc. (OKUR)vs › | $99.62M | N/A |
| Rallybio Corporation (RLYB)vs › | $90.64M | N/A |
| Biomea Fusion, Inc. (BMEA)vs › | $90.37M | $56.43M |
| ImmuCell Corporation (ICCC)vs › | $90.20M | $93.78M |
| Equillium, Inc. (EQ)vs › | $89.78M | $33.20M |
Market Cap
$95.14M
Total Debt
$57.84M
Cash
$73.05M
Enterprise Value
$79.93M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
